Lassmann H
Institute of Neurology, University of Vienna, Austria.
Acta Neurol Belg. 1999 Mar;99(1):6-10.
Although multiple sclerosis is generally believed to be a T-cell mediated inflammatory disease of the central nervous system, recent experimental and neuropathological studies show that additional pathogenetic factors are required to induce widespread primary demyelination and secondary tissue damage, such as axonal loss. This review summarises experimental evidence for multiple pathogenetic pathways, that can be responsible for myelin destruction in this disease. Furthermore, recent data are discussed which show that different immunopathological pathways seem to be involved in different patient subgroups. The pathogenetic heterogeneity of multiple sclerosis suggests that immunomodulatory treatment of this disease may be more complex than previously anticipated.
尽管多发性硬化症通常被认为是一种由T细胞介导的中枢神经系统炎性疾病,但最近的实验和神经病理学研究表明,还需要其他致病因素来引发广泛的原发性脱髓鞘和继发性组织损伤,如轴突损失。本综述总结了多种致病途径的实验证据,这些途径可能导致该疾病中的髓鞘破坏。此外,还讨论了最近的数据,这些数据表明不同的免疫病理途径似乎在不同的患者亚组中起作用。多发性硬化症的致病异质性表明,该疾病的免疫调节治疗可能比之前预期的更为复杂。